Radiography
Volume 18, Issue 1 , Pages 9-14 , February 2012

Correlation of number and identification of sentinel nodes during radiographer led lymphoscintigraphy prior to sentinel lymph node biopsy in breast cancer patients

  • Gail Camilleri

      Affiliations

    • Medical Imaging Department, Mater Dei Hospital, Malta
    • Tel.: +356 79921833.
  • ,
  • Karen Borg Grima

      Affiliations

    • Department of Radiography, Faculty of Health Sciences, University of Malta, Malta
    • Tel.: +356 23401812.
  • ,
  • Francis Zarb

      Affiliations

    • Department of Radiography, Faculty of Health Sciences, University of Malta, Malta
    • Corresponding Author InformationCorresponding author. Tel.: +356 23401833; fax: +356 21244975.

Received 28 September 2011 ,Revised 8 November 2011 ,Accepted 11 November 2011.

References 

  1. Rempp H. Sentinel lymph-node radiodetection in breast cancer: Results of a clinical study and development of a quantitative approach [Thesis]. Nice: Université de Nice Sophia-Antipolis; 2003. Available from: http://www.freidok.uni-freiburg.de/volltexte/2155/pdf/Sentinel_lymph_node_radiodetection_in_breast_cancer_.pdf [cited 2010 February 25].
  2. Tyczynski JE, Plesko I, Aareleid T, Primic-Zakelj M, Dalmas M, Kurtinaitis J, et al. Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer. 2004;112(6):1056–1064
  3. Cancer Research UK. Breast cancer – UK incidence statistics [Internet]; 2010. Available from: http://info.cancerresearchuk.org/cancerstats/types/breast/incidence/ [updated 2011 July 18; cited 2011 August 7].
  4. Ministry for Health, The Elderly and Community Care, Malta. The National Cancer Plan 2011–2015 (Internet); 2011. Available from: https://ehealth.gov.mt/download.aspx?id=5686 [cited 2011 July 9].
  5. Kowalsky RJ, Falen SW. In: Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed.. Washington, DC: American Pharmacists Association; 2004;
  6. Namwongprom S, Boonyaprapa S, Ekmahachai M, Vilasdechanon N, Somwangprasert A, Sumitsawan S, et al. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes. Singapore Med J. 2005;46(12):688–692
  7. Erb KM, Julian TB. Completion of axillary dissection for a positive sentinel node: necessary or not?. Curr Oncol Rep. 2009;11(1):15–20
  8. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer. 2003;89(4):648–652
  9. Collins CD. The sentinel node in breast cancer: An update. Cancer Imaging. 2005;5:S3–S9
  10. Sun X, Liu J-J, Wang Y-S, Wang L, Yang G-R, Zhou Z-B, et al. Roles of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer patients. Jpn J Clin Oncol. 2010;40(8):722–725
  11. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42(8):1198–1215
  12. Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8(6):538–541
  13. Krynyckyi BR, Shafir MK, Kim SC, Kim DW, Travis A, Moadel RM, et al. Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer. Int Semin Surg Oncol. 2005;2(25):
  14. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16
  15. Nakashima K, Kurebayashi J, Sonoo H, Tanaka K, Ikeda M, Shiiki S, et al. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer. Breast cancer. 2010;17(1):17–21
  16. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg. 2000;231(5):724–731
  17. Harlow SP. Is preoperative lymphoscintigraphy needed for sentinel node procedures in breast cancer?. Ann Surg Oncol. 2005;12(7):515–516
  18. Krynyckyi BR, Kim SC, Kim CK. Preoperative lymphoscintigraphy and triangulated patient body marking are important parts of the sentinel node process in breast cancer. World J Surg Oncol. 2005;3:56
  19. Kim SC, Kim DW, Moadel RM, Kim CK, Chatterjee S, Shafir MK, et al. Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature. World J Surg Oncol. 2005;3:64
  20. Noguchi M. Sentinel lymph node biopsy and breast cancer. Brit J Surg. 2002;89(1):21–34
  21. D’Eredita G, Giardina C, Guerrieri AM, Berardi T. A further validation of subareolar injection technique for breast sentinel lymph node biopsy. Ann Surg Oncol. 2006;13(5):701–707
  22. Doting MHE. Sentinel lymph node biopsy in breast cancer and melanoma [Thesis]. Groningen: University Medical Center Groningen; 2007. Available from: http://dissertations.ub.rug.nl/FILES/faculties/medicine/2007/m.h.e.doting/thesis.pdf [cited 2010 February 25].
  23. Haigh PI, Hansen NM, Giuliano AE, Edwards GK, Ye W, Glass EC. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med. 2000;41(10):1682–1688
  24. Birdwell RL, Smith KL, Betts BJ, Ikeda DM, Strauss HW, Jeffrey SS. Breast cancer: Variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology. 2001;220:47–53
  25. Brenot-Rossi I, Houvenaeghel G, Jacquemier J, Bardou V-J, Martino M, Hassan-Sebbag N, et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?. J Nucl Med. 2003;44(8):1232–1237
  26. Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield L, et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer. 2005;41(2):238–243
  27. Rousseau C, Classe JM, Campion L, Curtet C, Dravet F, Pioud R, et al. The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol. 2005;12(7):533–538
  28. Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity?. J Am Coll Surg. 2007;205:66–71
  29. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJH, Mansel RE, Bogaerts J, et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010;17(7):1854–1861
  30. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Rasoul Zakavi S, Memar B, Naser Forghani M, et al. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl. 2010;29(2):73–77
  31. Dupont EL, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, et al. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol. 2001;8(4):354–360
  32. Marchal F, Rauch P, Morel O, Mayer JC, Olivier P, Leroux A, et al. Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes. World J Surg. 2006;30:55–62
  33. Mathew MA, Saha AK, Saleem T, Saddozai N, Hutchinson IF, Nejim A. Pre-operative lymphoscintigraphy before sentinel lymph node biopsy for breast cancer. The Breast. 2010;19(1):28–32
  34. Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caracò C, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging. 2009;36(10):1713–1742
  35. East JM, Valentine CSP, Kanchev E, Blake GO. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg. 2009;9:2
  36. Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 2007;87(2):353–364
  37. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med. 2003;44(1):7–10
  38. Chagpar AB, Martin RC, Scoggins CR, Carlson DJ, Laidley AL, El-Eid SE, et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery. 2005;138:56–63
  39. Vlastos G, Verkooijen HM. Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. The Oncologist. 2007;12(1):1–10
  40. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med. 1997;38(3):366–368
  41. Burak WE, Walker MJ, Yee LD, Kim JA, Saha S, Hinkle G, et al. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg. 1999;177:445–449
  42. Wang L, Yu J-M, Wang Y-S, Zuo W-S, Gao Y, Fan J, et al. Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer. Ann Surg Oncol. 2007;14(8):2215–2220
  43. Duchaj B, Chvalny P, Vesely J, Makaiova I, Durdik S, Straka V, et al. Radionavigated detection of sentinel nodes in breast carcinoma - first experiences of our department. Bratisl Lek Listy. 2010;111(1):33–37
  44. Teal CB, Slocum JP, Akin EA, Kelly TA. Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer. Am J Surg. 2005;190(4):567–569
  45. Keshtgar MRS, Waddington WA, Lakhani SR, Ell PJ. The sentinel node in surgical oncology. Berlin, Germany: Springer-Verlag; 1999;

PII: S1078-8174(11)00140-4

doi: 10.1016/j.radi.2011.11.003

Radiography
Volume 18, Issue 1 , Pages 9-14 , February 2012